Peijia Medical to Vote on Director Re-elections, Deloitte Appointment, and Capital Mandates at 29 May 2026 AGM

Bulletin Express
04/23

Peijia Medical Limited has circulated its proxy form for the Annual General Meeting scheduled for 9:30 a.m. on Friday, 29 May 2026, at No. 18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu, China. Shareholders will decide on six ordinary resolutions that cover the company’s FY 2025 financial statements, board composition, auditor appointment, and share capital authorities.

Key items on the agenda include:

1. Financial Statements • Shareholders will consider and adopt the audited consolidated financial statements of Peijia Medical and its subsidiaries for the year ended 31 December 2025, together with the reports of the directors and auditor.

2. Board Composition and Remuneration • Re-election of four retiring directors: Executive Directors Dr. Yi Zhang and Ms. Hong Ye; Non-executive Director Mr. Jun Yang; and Independent Non-executive Director Dr. Stephen Newman Oesterle. • Authorisation for the board to determine directors’ remuneration.

3. Auditor Appointment • Appointment of Deloitte Touche Tohmatsu as the company’s auditor until the conclusion of the next AGM, with the board authorised to fix the auditor’s remuneration.

4. General Mandates on Share Capital • Authorise the board to allot, issue, and deal with additional shares— including the sale or transfer of any treasury shares—up to 20 % of the company’s issued share capital (excluding treasury shares) as at the date of approval. • Authorise the board to repurchase shares up to 10 % of issued share capital (excluding treasury shares). • Extend the share-issuance mandate by the amount of shares repurchased under the 10 % buy-back mandate.

Logistics and Voting • Shareholders may appoint one or more proxies; in the absence of a named proxy, the chairman of the meeting will act by default. • Completed proxy forms must reach Computershare Hong Kong Investor Services Limited by 9:30 a.m. on Wednesday, 27 May 2026 (Hong Kong time). • The proxy need not be a shareholder, and completion of the proxy form does not preclude shareholders from attending and voting in person.

The AGM decisions will shape Peijia Medical’s governance structure and provide the board with flexibility for future capital management during the next financial year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10